Atlas Venture Fund Ix, L.P. is > 10% Shareholder of Cogent Biosciences, Inc.. Currently has a direct ownership of 3.36 Million shares of COGT, which is worth approximately $30.7 Million. The most recent transaction as insider was on Apr 03, 2018, when has been sold 3,267,483 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.36M
0% 3M change
0% 12M change
Total Value Held $30.7 Million

Atlas Venture Fund IX, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2018
BUY
Conversion of derivative security
-
3,267,483 Added 50.0%
3,267,483 Common Stock
Apr 03 2018
BUY
Open market or private purchase
$1,128,624 $12.0 p/Share
94,052 Added 2.72%
3,361,535 Common Stock

Also insider at

SURF
Surface Oncology, Inc. Healthcare
AVF

Atlas Venture Fund Ix, L.P.

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on COGT

Follow Cogent Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COGT shares.

Notify only if

Insider Trading

Get notified when an Cogent Biosciences, Inc. insider buys or sells COGT shares.

Notify only if

News

Receive news related to Cogent Biosciences, Inc.

Track Activities on COGT